PharmaSGP Holding SE (PSG) - Cash Flow Conversion Efficiency

Latest as of March 2025: 0.115x

Based on the latest financial reports, PharmaSGP Holding SE (PSG) has a cash flow conversion efficiency ratio of 0.115x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€4.22 Million ≈ $4.94 Million USD) by net assets (€36.67 Million ≈ $42.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is PharmaSGP Holding SE's balance sheet to measure how much of total assets are equity-financed.

PharmaSGP Holding SE - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how PharmaSGP Holding SE's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check PharmaSGP Holding SE earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

PharmaSGP Holding SE Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PharmaSGP Holding SE ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
MMTEC Inc NASDAQ:MTC	-0.138x
Selvaag Bolig ASA OL:SBO	0.106x
Baader Bank Aktiengesellschaft F:BWB	N/A
Carlsmed, Inc. Common Stock NASDAQ:CARL	-0.141x
Good Finance Securities Co Ltd TWO:6021	-0.007x
Beijing Infosec Technologies Co. Ltd. A SHG:688201	N/A
EUROSEAS LTD DL -01 F:2LE1	N/A
Good Will Instrument Co Ltd TW:2423	-0.008x

Annual Cash Flow Conversion Efficiency for PharmaSGP Holding SE (2014–2024)

The table below shows the annual cash flow conversion efficiency of PharmaSGP Holding SE from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of PharmaSGP Holding SE.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€31.96 Million ≈ $37.37 Million	€24.88 Million ≈ $29.08 Million	0.778x	+16.15%
2023-12-31	€39.75 Million ≈ $46.48 Million	€26.64 Million ≈ $31.14 Million	0.670x	-15.68%
2022-12-31	€31.10 Million ≈ $36.36 Million	€24.71 Million ≈ $28.89 Million	0.795x	+44.12%
2021-12-31	€22.20 Million ≈ $25.95 Million	€12.24 Million ≈ $14.31 Million	0.551x	-58.95%
2020-12-31	€11.51 Million ≈ $13.45 Million	€15.46 Million ≈ $18.07 Million	1.343x	+628.25%
2019-12-31	€95.58 Million ≈ $111.74 Million	€17.63 Million ≈ $20.61 Million	0.184x	-20.63%
2017-12-31	€61.32 Million ≈ $71.68 Million	€14.25 Million ≈ $16.66 Million	0.232x	+276.99%
2016-12-31	€57.53 Million ≈ $67.26 Million	€3.55 Million ≈ $4.15 Million	0.062x	-68.67%
2015-12-31	€53.79 Million ≈ $62.88 Million	€10.59 Million ≈ $12.38 Million	0.197x	+75.71%
2014-12-31	€48.27 Million ≈ $56.43 Million	€5.41 Million ≈ $6.32 Million	0.112x	--

About PharmaSGP Holding SE

F:PSG Germany

Market Cap

$387.63 Million

€331.56 Million EUR

Market Cap Rank

#14301 Global

#1436 in Germany

Share Price

€28.80

Change (1 day)

+0.70%

52-Week Range

€28.60 - €29.00

All Time High

€32.32